Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Bayer Healthcare Pharmaceuticals Inc., BeiGene USA, Inc., BeyondSpring Pharmaceuticals, Inc., Bristol Myers Squibb, Daiichi Sankyo, Inc, Exact Sciences Corporation, G1 Therapeutics, Inc., Genentech, Inc., Jazz Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Regeneron Pharmaceuticals, Inc and Sanofi Genzyme, and Turning Point Therapeutics, Inc.

Community Practice Connections™: 16th Annual New York Lung Cancers Symposium®

Release Date: January 7, 2022
Expiration Date: January 7, 2023


Activity Overview

This Community Practice Connection™ program provides an in-depth review of some of the key highlights from the 16th Annual New York Lung Cancers Symposium®, held in November 2021. This unique and engaging multi-media activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with lung cancer, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AstraZeneca, Bayer Healthcare Pharmaceuticals Inc., BeiGene USA, Inc., BeyondSpring Pharmaceuticals, Inc., Bristol Myers Squibb, Daiichi Sankyo, Inc, Exact Sciences Corporation, G1 Therapeutics, Inc., Genentech, Inc., Jazz Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Regeneron Pharmaceuticals, Inc and Sanofi Genzyme, and Turning Point Therapeutics, Inc.
 

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.



Target Audience

This educational activity is directed toward medical oncologists, radiation oncologists, thoracic surgeons, and pulmonologists involved in the treatment and management of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, investigators, and other health care professionals interested in the treatment of lung cancer may also participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Evaluate testing strategies to optimize tumor characterization and inform clinical decision-making for the management of patients with lung cancers
  • Describe clinical trial evidence regarding the management of patients with non-metastatic lung cancers
  • Apply evidence concerning single-agent and combination immunotherapeutic approaches to manage lung cancers
  • Identify current and emerging therapeutic strategies over multiple lines of therapy for patients with oncogene-driven NSCLC subtypes
  • Outline strategies for patients without actionable oncogenic drivers, including the role of chemotherapies and antiangiogenic strategies
  • Summarize approaches to mitigate and manage treatment-related toxicities in the care of patients with lung cancers

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
 

Faculty

Balazs Halmos, MD, MS
Balazs Halmos, MD, MS
Professor of Clinical Medicine
Director, Thoracic/Head and Neck Oncology
Director, Clinical Cancer Genomics
Albert Einstein College of Medicine/Montefiore Medical Center
Bronx, NY

Disclosures: Grant/Research Support: Mirati, AstraZeneca, Merck, Bristol Myers Squibb, Pfizer, AbbVie, GSK, Advaxis, Blueprint, Amgen; Consultant: AstraZeneca, Pfizer, Boehringer-Ingelheim, Genentech, Novartis, Bristol Myers Squibb, Amgen, TPT, Apollomics.


Mark G. Kris, MD
Mark G. Kris, MD
Attending Physician, Thoracic Oncology Service
William and Joy Ruane Chair in Thoracic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY

Disclosures: Consultant: Astra Zeneca, Blueprint Medicines, BeiGene.

 
Roman Perez-Soler, MD
Roman Perez-Soler, MD
Chairman, Department of Oncology
Montefiore Medical Center
Professor of Medicine and Molecular Pharmacology
Deputy Director, Cancer Center
Albert Einstein College of Medicine
Bronx, NY

Disclosures: Consultant: Glaxo, Astra Zeneca, Clovis, Roche/Genentech, Boehringer, Lilly, Adgero; Shareholder: Stelexis.


Jamie E. Chaft, MD
Jamie E. Chaft, MD
Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, NY

Disclosures:  Grant/Research Support: Bristol Myers Squibb, Genentech, AstraZeneca, Merck; Consultant: Genentech, AstraZeneca, Merck, Bristol Myers Squibb, Flame Biosciences, Guardant Health, Novartis, Janssen, Regeneron.
 

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.



Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
 123456
78910111213
14151617181920
21222324252627
28293031
Filter By